LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block? - Wikidata - awgldk - TriplyDB

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

http://www.wikidata.org/entity/Q38416785

about

Small-molecule AT2 receptor agonists.A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug.Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology.Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.

P2860

Q36400573-3477F235-5184-40DD-9B5F-7933078AE82D Q38655266-1F0BA6FA-4153-494D-9C89-16C7ED5F9CD5 Q38671591-CEFE3432-6BE8-4653-A6A2-1B26BEF1C948 Q38847918-A40CF92D-96F5-47A7-8452-6C17BEAA82F1 Q47642528-208E95C0-C1DE-401F-9064-E6EE951F6BA9 Q52675558-C7F526E4-4FAB-4DC8-A939-C73903144F43

P2860

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

http://www.wikidata.org/entity/Q38416785

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

@en

type

label

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

@en

prefLabel

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

@en

P1433

Q38416785-0544CCEC-A0B7-40DD-A945-52E937F88BD7

P1476

Q38416785-71CADEAD-1486-4B92-BCBA-ED1CFF87053F

P2093

Q38416785-5954703C-91F0-466E-A12F-0C261340A004

Q38416785-9A053A71-1785-4008-89F9-415C655BFFFF

Q38416785-C39A7E86-53C2-435D-A663-890077B79E4A

P2860

Q38416785-04AD3A5B-71E7-4798-AB35-80ED87CE8673

Q38416785-0694FE39-2C41-4551-83AC-2C8100DE9E0A

Q38416785-135505CC-D2BA-4903-AF07-C3282E41F087

Q38416785-22CFE0F6-C4B5-4AD8-B6A2-843BA2C6A302

Q38416785-22F06ACF-238E-4A62-B7E6-9110922B2D8D

Q38416785-528FA849-60BF-422C-9B19-FC03DDBE40FB

Q38416785-5ACD17E1-E2F2-42DB-9849-C297CF5324CE

Q38416785-6D97D8BD-1AED-44FB-BACF-E9236CE3E98D

Q38416785-7138AE87-F9A3-4E03-86D3-BEFC261D952E

Q38416785-74993643-D3F7-4F50-B655-22A8A9CA0163

P304

Q38416785-951790B2-6757-48E9-ADF1-ABE7FE98887B

P31

Q38416785-47EB804B-00C4-4DC4-9D9D-CD56044479EB

P356

Q38416785-A17C9010-6F85-4CD9-B26C-52E492CAF041

P433

Q38416785-986925AE-3F72-44A7-9A41-5147BDB8C79A

P478

Q38416785-E53358DD-3ED7-4A85-A029-D5F493BD11F3

P577

Q38416785-D0C52073-E0F7-4CB5-A2E8-E6021FCBF770

P698

Q38416785-B5399C7D-7DC7-46F1-91C4-1318579B29AB

P356

0897190014568675

P1433

Journal of Pharmacy Practice

P1476

LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?

@en

P2093

Antony Q Pham

http://www.w3.org/2001/XMLSchema#string

Brittany Gallagher

http://www.w3.org/2001/XMLSchema#string

Yesha Patel

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Angiotensin-neprilysin inhibition versus enalapril in heart failure

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.

Effect of carvedilol on survival in severe chronic heart failure.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

P304

137-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0897190014568675

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25864789

http://www.w3.org/2001/XMLSchema#string